This compound is a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ether. It serves as a pharmaceutical intermediate, primarily used in solid-phase peptide synthesis as a building block.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 3020708-11-3
(2S,4R)-4-(tert-butoxy)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid
Fmoc-protected amino acid building block
(2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,4S)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
Pharmaceutical intermediate
N3-L-Val-OH (CHA)
pharmaceutical intermediate for peptide synthesis
Glycinamide hydrochloride
pharmaceutical intermediate for peptide synthesis
(2R)-1,4-bis[(tert-butoxy)carbonyl]piperazine-2-carboxylic acid
pharmaceutical intermediate for peptide synthesis
L-Aspartic acid, bis(1,1-dimethylethyl) ester, hydrochloride
pharmaceutical intermediate for peptide synthesis
(2S,3S)-3-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
Pharmaceutical intermediate
(2S,5R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-5-[(2-methylpropan-2-yl)oxy]piperidine-2-carboxylic acid
XSFVPSLXHLZRHD-ZHRRBRCNSA-N
CC(C)(C)O[C@@H]1CC[C@H](N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
—